ULTA BEAUTY, INC. (ULTA) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-08-01..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-08-01..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-08-01; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-08-01. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-08-01. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 12.96B USD | |
| Stock-based compensation | (m) | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 1.61B USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 | (m) | $12.96B | (m) | $1.61B | (m) | (m) | (m) | (m) | (m) |
| 2026-05-02 | (m) | $12.71B | (m) | $1.58B | (m) | (m) | (m) | (m) | (m) |
| 2026-01-31 | (m) | $12.39B | $37.43M | $1.53B | (m) | (m) | 0.30% | (m) | (m) |
| 2025-11-01 | (m) | $11.98B | (m) | $1.57B | (m) | (m) | (m) | (m) | (m) |
| 2025-08-02 | (m) | $11.65B | (m) | $1.58B | (m) | (m) | (m) | (m) | (m) |
| 2025-05-03 | (m) | $11.42B | (m) | $1.57B | (m) | (m) | (m) | (m) | (m) |
| 2025-02-01 | (m) | $11.30B | $42.79M | $1.56B | (m) | (m) | 0.38% | (m) | (m) |
| 2024-11-02 | (m) | $11.36B | (m) | $1.57B | (m) | (m) | (m) | (m) | (m) |
| 2024-08-03 | (m) | $11.32B | (m) | $1.57B | (m) | (m) | (m) | (m) | (m) |
| 2024-05-04 | (m) | $11.30B | (m) | $1.64B | (m) | (m) | (m) | (m) | (m) |
| 2024-02-03 | (m) | $11.21B | $48.25M | $1.68B | (m) | (m) | 0.43% | (m) | (m) |
| 2023-10-28 | (m) | $10.88B | (m) | $1.61B | (m) | (m) | (m) | (m) | (m) |
| 2023-07-29 | (m) | $10.73B | (m) | $1.64B | (m) | (m) | (m) | (m) | (m) |
| 2023-04-29 | (m) | $10.50B | (m) | $1.64B | (m) | (m) | (m) | (m) | (m) |
| 2023-01-28 | (m) | $10.21B | $43.04M | $1.64B | (m) | (m) | 0.42% | (m) | (m) |
| 2022-10-29 | (m) | $9.71B | (m) | $1.57B | (m) | (m) | (m) | (m) | (m) |
| 2022-07-30 | (m) | $9.37B | (m) | $1.49B | (m) | (m) | (m) | (m) | (m) |
| 2022-04-30 | (m) | $9.04B | (m) | $1.43B | (m) | (m) | (m) | (m) | (m) |
| 2022-01-29 | (m) | $8.63B | $47.26M | $1.30B | (m) | (m) | 0.55% | (m) | (m) |
| 2021-10-30 | (m) | $8.10B | (m) | $1.15B | (m) | (m) | (m) | (m) | (m) |
| 2021-07-31 | (m) | $7.66B | (m) | $963.18M | (m) | (m) | (m) | (m) | (m) |
| 2021-05-01 | (m) | $6.92B | (m) | $643.63M | (m) | (m) | (m) | (m) | (m) |
| 2021-01-30 | (m) | $6.15B | $27.58M | $236.82M | (m) | (m) | 0.45% | (m) | (m) |
| 2020-10-31 | (m) | $6.26B | (m) | $300.30M | (m) | (m) | (m) | (m) | (m) |
| 2020-08-01 | (m) | $6.39B | (m) | $366.81M | (m) | (m) | (m) | (m) | (m) |
| 2020-05-02 | (m) | $6.83B | (m) | $562.07M | (m) | (m) | (m) | (m) | (m) |
| 2020-02-01 | (m) | $7.40B | $25.64M | $901.09M | (m) | (m) | 0.35% | (m) | (m) |
| 2019-11-02 | (m) | $7.22B | (m) | $894.55M | (m) | (m) | (m) | (m) | (m) |
| 2019-08-03 | (m) | $7.09B | (m) | $895.98M | (m) | (m) | (m) | (m) | (m) |
| 2019-05-04 | (m) | $6.92B | (m) | $881.78M | (m) | (m) | (m) | (m) | (m) |
| 2019-02-02 | (m) | $6.72B | $27.49M | $854.08M | (m) | (m) | 0.41% | (m) | (m) |
| 2018-11-03 | (m) | $6.53B | $26.81M | $827.29M | (m) | (m) | 0.41% | (m) | (m) |
| 2018-08-04 | (m) | $6.31B | $25.92M | $820.74M | (m) | (m) | 0.41% | (m) | (m) |
| 2018-05-05 | (m) | $6.11B | $25.08M | $806.73M | (m) | (m) | 0.41% | (m) | (m) |
| 2018-02-03 | (m) | $5.88B | $24.40M | $785.29M | (m) | (m) | 0.41% | (m) | (m) |
| 2017-10-28 | (m) | $5.53B | $23.04M | $755.10M | (m) | (m) | 0.42% | (m) | (m) |
| 2017-07-29 | (m) | $5.32B | $22.13M | $732.10M | (m) | (m) | 0.42% | (m) | (m) |
| 2017-04-29 | (m) | $5.10B | $20.81M | $696.07M | (m) | (m) | 0.41% | (m) | (m) |
| 2017-01-28 | (m) | $4.85B | $19.34M | $654.82M | (m) | (m) | 0.40% | (m) | (m) |
| 2016-10-29 | (m) | $4.54B | $18.67M | $600.08M | (m) | (m) | 0.41% | (m) | (m) |
| 2016-07-30 | (m) | $4.32B | $16.88M | $571.19M | (m) | (m) | 0.39% | (m) | (m) |
| 2016-04-30 | (m) | $4.13B | $16.27M | $545.88M | (m) | (m) | 0.39% | (m) | (m) |
| 2016-01-30 | (m) | $3.92B | $15.59M | $506.30M | (m) | (m) | 0.40% | (m) | (m) |
| 2015-10-31 | (m) | $3.70B | $14.61M | $474.28M | (m) | (m) | 0.39% | (m) | (m) |
| 2015-08-01 | (m) | $3.54B | $14.90M | $457.60M | (m) | (m) | 0.42% | (m) | (m) |
| 2015-05-02 | (m) | $3.40B | $14.20M | $437.12M | (m) | (m) | 0.42% | (m) | (m) |
| 2015-01-31 | (m) | $3.24B | $14.92M | $410.42M | (m) | (m) | 0.46% | (m) | (m) |
| 2014-11-01 | (m) | $3.06B | $15.50M | $387.09M | (m) | (m) | 0.51% | (m) | (m) |
| 2014-08-02 | (m) | $2.93B | $16.07M | $365.88M | (m) | (m) | 0.55% | (m) | (m) |
| 2014-05-03 | (m) | $2.80B | $17.02M | $340.77M | (m) | (m) | 0.61% | (m) | (m) |
| 2014-02-01 | (m) | $2.67B | $16.00M | $327.59M | (m) | (m) | 0.60% | (m) | (m) |
| 2013-11-02 | (m) | $2.56B | $15.59M | $317.22M | (m) | (m) | 0.61% | (m) | (m) |
| 2013-08-03 | (m) | $2.45B | $14.57M | $305.64M | (m) | (m) | 0.60% | (m) | (m) |
| 2013-05-04 | (m) | $2.33B | $13.53M | $290.23M | (m) | (m) | 0.58% | (m) | (m) |
| 2013-02-02 | (m) | $2.22B | $13.38M | $279.98M | $185.00K | (m) | 0.60% | 1513.39× | Reported |
| 2012-10-27 | (m) | $2.04B | $13.10M | $249.46M | $255.00K | (m) | 0.64% | 978.27× | Reported |
| 2012-07-28 | (m) | $1.95B | $12.76M | $232.38M | $392.00K | (m) | 0.65% | 592.81× | Reported |
| 2012-04-28 | (m) | $1.86B | $11.69M | $214.58M | $435.00K | (m) | 0.63% | 493.29× | Reported |
| 2012-01-28 | (m) | $1.78B | $11.61M | $196.19M | $587.00K | (m) | 0.65% | 334.23× | Reported |
| 2011-10-29 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-07-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-01-29 | (m) | $1.45B | $11.15M | $118.88M | $755.00K | (m) | 0.77% | 157.46× | Reported |
| 2010-10-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-05-01 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-01-30 | (m) | $1.22B | $5.95M | $68.15M | $2.20M | (m) | 0.49% | 30.95× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bath & Body Works, Inc. (BBWI) | United States | $3.384B | 5.20 |
| Sally Beauty Holdings, Inc. (SBH) | United States | $1.593B | 6.92 |
| Titan Machinery Inc. (TITN) | United States | $0.553B | -7.05 |
| STAR GROUP, L.P. (SGU) | United States | $0.415B | |
| Bark, Inc. (BARK) | United States | $0.073B | -3.19 |
| Rent the Runway, Inc. (RENT) | United States | $0.060B | |
| INNO HOLDINGS INC. (INHD) | Hong Kong | $0.008B | |
| Leslie's, Inc. (LESL) | United States | $0.003B | -0.33 |